<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors report about a retrospective series of 19 operated patients with <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> in a <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar lined esophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The resection rate was 95%, the postoperative mortality rate was 5.5% </plain></SENT>
<SENT sid="2" pm="."><plain>The survival rate following curative exeresis (n = 14) was 32% (+/- 14) at 5 years </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with a stage III lesion died after 2 years, while 46% (+/- 19) of those with stage I or II <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (p less than 0.001) survived at 5 years </plain></SENT>
<SENT sid="4" pm="."><plain>In a multivariative analysis, the most important prognostic factor is the histological grade (p less than 0.01), then the extension to the lymph nodes (p less than 0.1) </plain></SENT>
<SENT sid="5" pm="."><plain>As the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> often reveals the <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar lined esophagus</z:e>, the improvement of the prognosis certainly depends on the evaluation of the treatment, which combines pre- or postoperative radiation and chemotherapy, in multidepartmental prospective studies </plain></SENT>
</text></document>